Release Date: 23/06/15 13:23 Summary: New Zealand Patent Granted Price Sensitive: Yes Download Document 875.08KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%